About Flownamics, inc.
Flownamics, Inc. is a leading provider of automated bioreactor sampling solutions that are revolutionizing the bioprocessing industry. The company's products help optimize fermentation and bioreactor processes, enabling researchers and manufacturers to achieve greater efficiency, accuracy, and consistency in their operations.
Founded in 1995 by a team of experienced scientists and engineers, Flownamics has been at the forefront of innovation in the field of bioprocessing for over two decades. The company's flagship product line, known as the Seg-Flow system, is designed to automate the sampling process for bioreactors used in research labs and manufacturing facilities.
The Seg-Flow system consists of a series of sensors that monitor key parameters such as pH levels, dissolved oxygen levels, temperature, and pressure inside the bioreactor. These sensors are connected to an automated sampler that collects samples at predetermined intervals based on user-defined criteria.
One of the key advantages of Flownamics' automated sampling technology is its ability to provide real-time data on fermentation processes. This allows researchers and manufacturers to make informed decisions about when to add nutrients or adjust other variables during production runs.
In addition to its flagship Seg-Flow system, Flownamics also offers a range of other products designed to support bioprocessing operations. These include software tools for data analysis and visualization as well as hardware components such as pumps and valves.
Flownamics' commitment to quality is reflected in its ISO 9001:2015 certification for quality management systems. The company also maintains an active research program aimed at developing new technologies that can further improve efficiency and productivity in bioprocessing operations.
Overall, Flownamics' innovative solutions have helped transform the way researchers and manufacturers approach fermentation processes. With its cutting-edge technology and commitment to excellence, this company is poised for continued success in this rapidly evolving field.